205 related articles for article (PubMed ID: 11880384)
1. Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines.
Zhou N; Luo Z; Luo J; Fan X; Cayabyab M; Hiraoka M; Liu D; Han X; Pesavento J; Dong CZ; Wang Y; An J; Kaji H; Sodroski JG; Huang Z
J Biol Chem; 2002 May; 277(20):17476-85. PubMed ID: 11880384
[TBL] [Abstract][Full Text] [Related]
2. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
[TBL] [Abstract][Full Text] [Related]
3. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
[TBL] [Abstract][Full Text] [Related]
4. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
5. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.
Zhou N; Luo Z; Luo J; Hall JW; Huang Z
Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.
Zhou N; Luo Z; Luo J; Liu D; Hall JW; Pomerantz RJ; Huang Z
J Biol Chem; 2001 Nov; 276(46):42826-33. PubMed ID: 11551942
[TBL] [Abstract][Full Text] [Related]
7. NMR structures of anti-HIV D-peptides derived from the N-terminus of viral chemokine vMIP-II.
Mori M; Liu D; Kumar S; Huang Z
Biochem Biophys Res Commun; 2005 Sep; 335(3):651-8. PubMed ID: 16115468
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop.
Zhu R; Meng Q; Zhang H; Zhang G; Huang LSM; Xu Y; Schooley RT; An J; Huang Z
Eur J Med Chem; 2022 Dec; 244():114797. PubMed ID: 36270088
[TBL] [Abstract][Full Text] [Related]
9. Unmasking ligand binding motifs: identification of a chemokine receptor motif by NMR studies of antagonist peptides.
Booth V; Slupsky CM; Clark-Lewis I; Sykes BD
J Mol Biol; 2003 Mar; 327(2):329-34. PubMed ID: 12628240
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
Hesselgesser J; Liang M; Hoxie J; Greenberg M; Brass LF; Orsini MJ; Taub D; Horuk R
J Immunol; 1998 Jan; 160(2):877-83. PubMed ID: 9551924
[TBL] [Abstract][Full Text] [Related]
11. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.
Fenard D; Lambeau G; Maurin T; Lefebvre JC; Doglio A
Mol Pharmacol; 2001 Aug; 60(2):341-7. PubMed ID: 11455021
[TBL] [Abstract][Full Text] [Related]
12. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
[TBL] [Abstract][Full Text] [Related]
14. A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry.
Choi WT; Kumar S; Madani N; Han X; Tian S; Dong CZ; Liu D; Duggineni S; Yuan J; Sodroski JG; Huang Z; An J
Biochemistry; 2012 Sep; 51(36):7078-86. PubMed ID: 22897429
[TBL] [Abstract][Full Text] [Related]
15. The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.
Luo Z; Zhou N; Luo J; Hall JW; Huang Z
Biochem Biophys Res Commun; 1999 Oct; 263(3):691-5. PubMed ID: 10512741
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
Gerlach LO; Skerlj RT; Bridger GJ; Schwartz TW
J Biol Chem; 2001 Apr; 276(17):14153-60. PubMed ID: 11154697
[TBL] [Abstract][Full Text] [Related]
17. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha.
Gozansky EK; Louis JM; Caffrey M; Clore GM
J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815
[TBL] [Abstract][Full Text] [Related]
18. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).
Veldkamp CT; Seibert C; Peterson FC; Sakmar TP; Volkman BF
J Mol Biol; 2006 Jun; 359(5):1400-9. PubMed ID: 16725153
[TBL] [Abstract][Full Text] [Related]
19. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.
Crump MP; Gong JH; Loetscher P; Rajarathnam K; Amara A; Arenzana-Seisdedos F; Virelizier JL; Baggiolini M; Sykes BD; Clark-Lewis I
EMBO J; 1997 Dec; 16(23):6996-7007. PubMed ID: 9384579
[TBL] [Abstract][Full Text] [Related]
20. Role of CXCR4 internalization in the anti-HIV activity of stromal cell-derived factor-1α probed by a novel synthetically and modularly modified-chemokine analog.
Dong CZ; Tian S; Madani N; Choi WT; Kumar S; Liu D; Sodroski JG; Huang Z; An J
Exp Biol Med (Maywood); 2011 Dec; 236(12):1413-9. PubMed ID: 22101518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
